enzalutamide,talazoparib
astellas,pfizer
['talapro,2', 'pcsm', 'talazo', 'enzalu', 'crpc', 'enzalutamide', 'talapro-2']
according to safety results from the phase 3 talapro-2 study talazoparib plus enzalutamide was a tolerable treatment, with dose modifications or standard supportive care, for men with metastatic crpc. #pcsm #asco23 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.